BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16946003)

  • 1. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
    Reddi HV; McIver B; Grebe SK; Eberhardt NL
    Endocrinology; 2007 Mar; 148(3):932-5. PubMed ID: 16946003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
    Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice.
    Diallo-Krou E; Yu J; Colby LA; Inoki K; Wilkinson JE; Thomas DG; Giordano TJ; Koenig RJ
    Endocrinology; 2009 Nov; 150(11):5181-90. PubMed ID: 19797117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.
    Eberhardt NL; Grebe SK; McIver B; Reddi HV
    Mol Cell Endocrinol; 2010 May; 321(1):50-6. PubMed ID: 19883731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
    Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
    Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX8PPARgamma stimulates cell viability and modulates expression of thyroid-specific genes in a human thyroid cell line.
    Espadinha C; Cavaco BM; Leite V
    Thyroid; 2007 Jun; 17(6):497-509. PubMed ID: 17614769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
    Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
    Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPARγ Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1).
    Xu B; O'Donnell M; O'Donnell J; Yu J; Zhang Y; Sartor MA; Koenig RJ
    J Biol Chem; 2016 Sep; 291(37):19274-86. PubMed ID: 27435678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PAX8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma.
    McIver B; Grebe SK; Eberhardt NL
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):221-34. PubMed ID: 15379724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
    Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
    Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
    Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
    Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.
    Dobson ME; Diallo-Krou E; Grachtchouk V; Yu J; Colby LA; Wilkinson JE; Giordano TJ; Koenig RJ
    Endocrinology; 2011 Nov; 152(11):4455-65. PubMed ID: 21952241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth.
    Au AY; McBride C; Wilhelm KG; Koenig RJ; Speller B; Cheung L; Messina M; Wentworth J; Tasevski V; Learoyd D; Robinson BG; Clifton-Bligh RJ
    Endocrinology; 2006 Jan; 147(1):367-76. PubMed ID: 16179407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.
    Armstrong MJ; Yang H; Yip L; Ohori NP; McCoy KL; Stang MT; Hodak SP; Nikiforova MN; Carty SE; Nikiforov YE
    Thyroid; 2014 Sep; 24(9):1369-74. PubMed ID: 24798894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
    Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
    Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists.
    Salajegheh A; Petcu EB; Smith RA; Lam AK
    Postgrad Med J; 2008 Feb; 84(988):78-82. PubMed ID: 18322127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
    Raman P; Koenig RJ
    Nat Rev Endocrinol; 2014 Oct; 10(10):616-23. PubMed ID: 25069464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.